Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.
about
Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approachesDiffusion tensor imaging for target volume definition in glioblastoma multiforme.Positron emission tomography of high-grade gliomas.Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma.Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesionsFrom the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).Contribution of (18)F-Fluoro-ethyl-tyrosine Positron Emission Tomography to Target Volume Delineation in Stereotactic Radiotherapy of Malignant Cranial Base Tumours: First Clinical ExperienceIntegration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost.Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas.Improved outcomes with intensity modulated radiation therapy combined with temozolomide for newly diagnosed glioblastoma multiforme.Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?PET imaging in glioma: is it time for mainstream practice?Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients.Quasi-VMAT in high-grade glioma radiation therapy.Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy.RESOLUTE PET/MRI Attenuation Correction for O-(2-18F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants.Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicine.Usefulness of PET Imaging to Guide Treatment Options in Gliomas.Relationship between Glioblastoma Dose Volume Parameters Measured by Dual Time Point Fluoroethylthyrosine-PET and Clinical Outcomes.Functional image-guided dose escalation in gliomas using of state-of-the-art photon vs. proton therapy.Survival after radiation therapy for high-grade glioma
P2860
Q30725125-FC8F95B7-60A8-4295-A873-D60C8AA82C8FQ30819602-EB51F1F4-DE26-4A84-8C9F-6BA1C19021F2Q31047940-65FA842B-C315-462F-898E-FC699BCD73C2Q33716525-4E7D0758-FB89-4260-BA6A-4282C6C009C3Q34691877-A0314EE3-7B14-440D-9736-ABC495EDAFD2Q35093266-72976509-BAD3-4794-B129-337BA127DF3AQ35679377-98661427-200D-4818-8537-00042513B3FDQ35788602-CE5F14E4-877E-4A0C-B5A2-1EE59F604EB0Q36157048-1CD193FA-0600-4A99-BD62-EDAA82B52400Q36413724-6C6187F0-453F-459D-9D96-7CA82D6953AAQ36555913-F7146EC5-D1F9-4A8A-8B24-DD8C0C5A5BFBQ37037922-E2DAF36E-BD40-4476-8CBD-65B6093A1926Q37042526-5B3E839D-99B9-46D5-B7A3-447F91B048D3Q38051641-4A52A710-40EE-4D79-BBDF-B0AED3A08366Q38108186-935899AF-6C81-4150-8136-2B446CF293ADQ38815396-D82F842E-413F-4F22-986F-96FBB2EE8BA8Q39510956-C3CB81AE-BD98-4064-BBBD-4371F67DD362Q41581761-66C95D7A-62DA-4FA3-AFA8-047E768A2E18Q41922062-93CAEDB3-258C-41CB-A4B2-5AFD0147A5F2Q42234940-F1E49BE0-6308-44A1-9C16-79856C7A77B8Q42332774-9CAE569C-1109-40B5-9910-3902A93A010FQ45056685-617D8D4C-DF6D-4316-8ECE-279310F5C1BFQ45349539-DDDBAEF5-49FF-421A-9B4E-A7DACD59979AQ47094808-9DFDA8B1-179F-4ED2-B060-695708611FD3Q47911695-8B88BD88-36CD-421D-A1A5-96D2D6737467Q48139391-045F6893-967D-4CA1-8544-A6433D99E4EAQ48947048-D0613B4B-2EB9-4EB8-ABC2-72B76F3412DCQ49770817-AD89C6B0-6689-4218-BBC4-9AD9148BEA95Q52096609-C0B036D4-ABFD-40C1-86ED-67434535CB95Q58544790-77963932-913A-451B-B35B-3659353ACDB2
P2860
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Integrated boost IMRT with FET ...... a prospective phase II study.
@en
Integrated boost IMRT with FET ...... a prospective phase II study.
@nl
type
label
Integrated boost IMRT with FET ...... a prospective phase II study.
@en
Integrated boost IMRT with FET ...... a prospective phase II study.
@nl
prefLabel
Integrated boost IMRT with FET ...... a prospective phase II study.
@en
Integrated boost IMRT with FET ...... a prospective phase II study.
@nl
P2093
P2860
P1476
Integrated boost IMRT with FET ...... f a prospective phase II study
@en
P2093
H H Coenen
H J Kaiser
M D Piroth
N Galldiks
P2860
P2888
P304
P356
10.1007/S00066-011-0060-5
P577
2012-02-22T00:00:00Z